Back to search
Fulminant Clostridium Difficile Colitis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Fulminant Clostridium Difficile Colitis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Fulminant Clostridium Difficile Colitis trials you may qualify forA new medication, Bezlotoxumab, has been approved for treatment of recurrent Clostridium difficile diarrhea by the U.S. Food and Drug Administration. The way th…
LAY SUMMARY Clostridium Difficile (C.difficile) is a bacterial infection that can cause an inflammation of the colon, (C.difficile colitis). This sometimes pro…
The investigators hypothesize that minimally invasive ileal diversion with intraoperative colonic lavage using a high volume polyethylene glycol/electrolyte sol…